# Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/burden-of-infections-among-chronic-myeloid-leukemia-patients-receiving-dasatinib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Karen Seiter,Dominick Latrémouille-Viau,Annie Guérin,Briana Ndife,Karen Habucky,Derek Tang,Irina Pivneva,Patrick Gagnon‐Sanschagrin,George J Joseph |
| Citations | 17 |
| DOI | 10.1007/s12325-018-0772-3 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2888908066 |
| PMID | 30155792 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Briana Ndife](https://scholariq.org/researchers/briana-ndife/)

## Paper journal

- [Advances in Therapy](https://scholariq.org/journals/advances-in-therapy/)

## Paper primary topic

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Paper topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.